A Phase I DDI Study Between ACH-0144471 and Midazolam, Fexofenadine and Mycophenolate Mofetil

Condition:   Drug Interaction Potentiation Interventions:   Drug: Part 1, Period 1;   Drug: Part 1, Period 2;   Drug: Part 2, Period 1;   Drug: Part 2, Period 2;   Drug: Part 3, Period 1;   Drug: Part 3, Period 2 Sponsor:   Achillion Pharmaceuticals Not yet recruiting - verified April 2017

Source: ClinicalTrials.gov - March 28, 2017 Category: Research Source Type: clinical trials